Ovarian dysgerminoma: A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity

S. J. Buskirk, M. F. Schray, K. C. Podratz, R. A. Lee, C. R. Stanhope, T. A. Gaffey, F. C. Weber, J. D. Early, James M Naessens, G. D. Malkasian

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Thirty-five patients with a diagnosis of pure ovarian dysgerminoma underwent assessment at our institution between 1950 and 1984. The median age of these patients was 21 years (range, 8 to 41 years). The surgical pathologic stages of the tumors were as follows: stage IA1 in 18 patients, stage IA2 in 2, stage IB1 in 2, stage IC in 1, stage IIB in 2, stage III in 9, and stage IV in 1. The overall survival at 5, 10, and 20 years was 94.3%, 82.9%, and 82.95, respectively, for all 35 patients and 100%, 83.9%, and 83.9%, respectively, for the 18 patients with stage IA1 lesions. The maximum interval from diagnosis to relapse was 3.7 years. All patients were under surveillance for a minimum of 2 years (median follow-up, 15.9 years). Of the 18 patients with stage IA1 disease, 16 did not receive prophylactic radiation therapy to the para-aortic lymph nodes, and in 6 of the 16 (38%) recurrent disease developed in this region. Five of these patients were salvaged with radiation therapy and one with radiation therapy and subsequent chemotherapy. No definite correlation was noted between the size or mass of the resected unilateral encapsulated tumor and the risk of development of recurrent disease. For patients with stage IA1 dysgerminoma who have undergone unilateral oophorectomy, two treatment options seem reasonable: (1) observation, with radiation therapy reserved for subsequent recurrence, or (2) prophylactic radiation therapy (2,000 cGy) to para-aortic and ipsilateral common iliac lymph nodes, which would preserve fertility.

Original languageEnglish (US)
Pages (from-to)1149-1157
Number of pages9
JournalMayo Clinic Proceedings
Volume62
Issue number12
StatePublished - 1987

Fingerprint

Dysgerminoma
Radiation Tolerance
Treatment Failure
Radiotherapy
Therapeutics
Lymph Nodes
Recurrence
Ovariectomy
Fertility
Neoplasms
Observation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Buskirk, S. J., Schray, M. F., Podratz, K. C., Lee, R. A., Stanhope, C. R., Gaffey, T. A., ... Malkasian, G. D. (1987). Ovarian dysgerminoma: A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clinic Proceedings, 62(12), 1149-1157.

Ovarian dysgerminoma : A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity. / Buskirk, S. J.; Schray, M. F.; Podratz, K. C.; Lee, R. A.; Stanhope, C. R.; Gaffey, T. A.; Weber, F. C.; Early, J. D.; Naessens, James M; Malkasian, G. D.

In: Mayo Clinic Proceedings, Vol. 62, No. 12, 1987, p. 1149-1157.

Research output: Contribution to journalArticle

Buskirk, SJ, Schray, MF, Podratz, KC, Lee, RA, Stanhope, CR, Gaffey, TA, Weber, FC, Early, JD, Naessens, JM & Malkasian, GD 1987, 'Ovarian dysgerminoma: A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity', Mayo Clinic Proceedings, vol. 62, no. 12, pp. 1149-1157.
Buskirk SJ, Schray MF, Podratz KC, Lee RA, Stanhope CR, Gaffey TA et al. Ovarian dysgerminoma: A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clinic Proceedings. 1987;62(12):1149-1157.
Buskirk, S. J. ; Schray, M. F. ; Podratz, K. C. ; Lee, R. A. ; Stanhope, C. R. ; Gaffey, T. A. ; Weber, F. C. ; Early, J. D. ; Naessens, James M ; Malkasian, G. D. / Ovarian dysgerminoma : A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity. In: Mayo Clinic Proceedings. 1987 ; Vol. 62, No. 12. pp. 1149-1157.
@article{e6dee81c4960485e9c44d9c75d1e499e,
title = "Ovarian dysgerminoma: A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity",
abstract = "Thirty-five patients with a diagnosis of pure ovarian dysgerminoma underwent assessment at our institution between 1950 and 1984. The median age of these patients was 21 years (range, 8 to 41 years). The surgical pathologic stages of the tumors were as follows: stage IA1 in 18 patients, stage IA2 in 2, stage IB1 in 2, stage IC in 1, stage IIB in 2, stage III in 9, and stage IV in 1. The overall survival at 5, 10, and 20 years was 94.3{\%}, 82.9{\%}, and 82.95, respectively, for all 35 patients and 100{\%}, 83.9{\%}, and 83.9{\%}, respectively, for the 18 patients with stage IA1 lesions. The maximum interval from diagnosis to relapse was 3.7 years. All patients were under surveillance for a minimum of 2 years (median follow-up, 15.9 years). Of the 18 patients with stage IA1 disease, 16 did not receive prophylactic radiation therapy to the para-aortic lymph nodes, and in 6 of the 16 (38{\%}) recurrent disease developed in this region. Five of these patients were salvaged with radiation therapy and one with radiation therapy and subsequent chemotherapy. No definite correlation was noted between the size or mass of the resected unilateral encapsulated tumor and the risk of development of recurrent disease. For patients with stage IA1 dysgerminoma who have undergone unilateral oophorectomy, two treatment options seem reasonable: (1) observation, with radiation therapy reserved for subsequent recurrence, or (2) prophylactic radiation therapy (2,000 cGy) to para-aortic and ipsilateral common iliac lymph nodes, which would preserve fertility.",
author = "Buskirk, {S. J.} and Schray, {M. F.} and Podratz, {K. C.} and Lee, {R. A.} and Stanhope, {C. R.} and Gaffey, {T. A.} and Weber, {F. C.} and Early, {J. D.} and Naessens, {James M} and Malkasian, {G. D.}",
year = "1987",
language = "English (US)",
volume = "62",
pages = "1149--1157",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "12",

}

TY - JOUR

T1 - Ovarian dysgerminoma

T2 - A retrospctive analysis of results of treatment, sites of treatment failure, and radiosensitivity

AU - Buskirk, S. J.

AU - Schray, M. F.

AU - Podratz, K. C.

AU - Lee, R. A.

AU - Stanhope, C. R.

AU - Gaffey, T. A.

AU - Weber, F. C.

AU - Early, J. D.

AU - Naessens, James M

AU - Malkasian, G. D.

PY - 1987

Y1 - 1987

N2 - Thirty-five patients with a diagnosis of pure ovarian dysgerminoma underwent assessment at our institution between 1950 and 1984. The median age of these patients was 21 years (range, 8 to 41 years). The surgical pathologic stages of the tumors were as follows: stage IA1 in 18 patients, stage IA2 in 2, stage IB1 in 2, stage IC in 1, stage IIB in 2, stage III in 9, and stage IV in 1. The overall survival at 5, 10, and 20 years was 94.3%, 82.9%, and 82.95, respectively, for all 35 patients and 100%, 83.9%, and 83.9%, respectively, for the 18 patients with stage IA1 lesions. The maximum interval from diagnosis to relapse was 3.7 years. All patients were under surveillance for a minimum of 2 years (median follow-up, 15.9 years). Of the 18 patients with stage IA1 disease, 16 did not receive prophylactic radiation therapy to the para-aortic lymph nodes, and in 6 of the 16 (38%) recurrent disease developed in this region. Five of these patients were salvaged with radiation therapy and one with radiation therapy and subsequent chemotherapy. No definite correlation was noted between the size or mass of the resected unilateral encapsulated tumor and the risk of development of recurrent disease. For patients with stage IA1 dysgerminoma who have undergone unilateral oophorectomy, two treatment options seem reasonable: (1) observation, with radiation therapy reserved for subsequent recurrence, or (2) prophylactic radiation therapy (2,000 cGy) to para-aortic and ipsilateral common iliac lymph nodes, which would preserve fertility.

AB - Thirty-five patients with a diagnosis of pure ovarian dysgerminoma underwent assessment at our institution between 1950 and 1984. The median age of these patients was 21 years (range, 8 to 41 years). The surgical pathologic stages of the tumors were as follows: stage IA1 in 18 patients, stage IA2 in 2, stage IB1 in 2, stage IC in 1, stage IIB in 2, stage III in 9, and stage IV in 1. The overall survival at 5, 10, and 20 years was 94.3%, 82.9%, and 82.95, respectively, for all 35 patients and 100%, 83.9%, and 83.9%, respectively, for the 18 patients with stage IA1 lesions. The maximum interval from diagnosis to relapse was 3.7 years. All patients were under surveillance for a minimum of 2 years (median follow-up, 15.9 years). Of the 18 patients with stage IA1 disease, 16 did not receive prophylactic radiation therapy to the para-aortic lymph nodes, and in 6 of the 16 (38%) recurrent disease developed in this region. Five of these patients were salvaged with radiation therapy and one with radiation therapy and subsequent chemotherapy. No definite correlation was noted between the size or mass of the resected unilateral encapsulated tumor and the risk of development of recurrent disease. For patients with stage IA1 dysgerminoma who have undergone unilateral oophorectomy, two treatment options seem reasonable: (1) observation, with radiation therapy reserved for subsequent recurrence, or (2) prophylactic radiation therapy (2,000 cGy) to para-aortic and ipsilateral common iliac lymph nodes, which would preserve fertility.

UR - http://www.scopus.com/inward/record.url?scp=0023522228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023522228&partnerID=8YFLogxK

M3 - Article

C2 - 3682960

AN - SCOPUS:0023522228

VL - 62

SP - 1149

EP - 1157

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 12

ER -